0001209191-23-051502.txt : 20231003
0001209191-23-051502.hdr.sgml : 20231003
20231003163635
ACCESSION NUMBER: 0001209191-23-051502
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231001
FILED AS OF DATE: 20231003
DATE AS OF CHANGE: 20231003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alder Matthias
CENTRAL INDEX KEY: 0001370820
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40237
FILM NUMBER: 231304446
MAIL ADDRESS:
STREET 1: C/O MICROMET, INC.
STREET 2: 6707 DEMOCRACY BLVD., STE. 505
CITY: BETHESDA
STATE: MD
ZIP: 28017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gain Therapeutics, Inc.
CENTRAL INDEX KEY: 0001819411
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851726310
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4800 HAMPDEN LANE
STREET 2: SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: (301) 500-1556
MAIL ADDRESS:
STREET 1: 4800 HAMPDEN LANE
STREET 2: SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-01
0
0001819411
Gain Therapeutics, Inc.
GANX
0001370820
Alder Matthias
C/O GAIN THERAPEUTICS, INC.
4800 MONTGOMERY LANE, SUITE 220
BETHESDA
MD
20814
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-10-01
4
M
0
825
A
6675
D
Restricted Stock Units
2023-10-01
4
M
0
825
0.00
D
Common Stock
825
9075
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
/s/ Jason Minio, Attorney-in-Fact
2023-10-03